Rezafungin

Chemical formula: C₆₃H₈₅N₈O₁₇⁺  Molecular mass: 1,225.603 g/mol  PubChem compound: 78318119

Therapeutic indications

Rezafungin is indicated for:

Invasive candidiasis

Population group: only adults (18 years old or older)

Rezafungin is indicated for the treatment of invasive candidiasis in adults.

Consideration should be given to official guidance on the appropriate use of antifungal agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Rezafungin is contraindicated in the following cases:

Lactation

Lactation

Hypersensitivity to medicinal products of the echinocandin class

Drug-induced anaphylaxis and additionally Echinocandin

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2023: REZZAYO Powder for solution for injection
Summary of Product Characteristics (SPC) 2024: REZZAYO Powder for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈